ID   ISCU_HUMAN              Reviewed;         167 AA.
AC   Q9H1K1; Q6P713; Q99617; Q9H1K2;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   18-JUN-2025, entry version 194.
DE   RecName: Full=Iron-sulfur cluster assembly enzyme ISCU {ECO:0000305};
DE   AltName: Full=NifU-like N-terminal domain-containing protein;
DE   AltName: Full=NifU-like protein;
DE   Flags: Precursor;
GN   Name=ISCU {ECO:0000312|HGNC:HGNC:29882}; Synonyms=NIFUN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   INTERACTION WITH NFS1, TISSUE SPECIFICITY, AND VARIANT VAL-12.
RX   PubMed=11060020; DOI=10.1093/emboj/19.21.5692;
RA   Tong W.-H., Rouault T.;
RT   "Distinct iron-sulfur cluster assembly complexes exist in the cytosol and
RT   mitochondria of human cells.";
RL   EMBO J. 19:5692-5700(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-12.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 47-167, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=8875867; DOI=10.1007/bf02337525;
RA   Hwang D.M., Dempsey A., Tan K.-T., Liew C.-C.;
RT   "A modular domain of NifU, a nitrogen fixation cluster protein, is highly
RT   conserved in evolution.";
RL   J. Mol. Evol. 43:536-540(1996).
RN   [5]
RP   FUNCTION (ISOFORM 2).
RX   PubMed=16517407; DOI=10.1016/j.cmet.2006.02.003;
RA   Tong W.H., Rouault T.A.;
RT   "Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-
RT   sulfur cluster biogenesis and iron homeostasis.";
RL   Cell Metab. 3:199-210(2006).
RN   [6]
RP   INTERACTION WITH NFS1 (ISOFORM 2), AND FUNCTION (ISOFORM 2).
RX   PubMed=16527810; DOI=10.1074/jbc.m600582200;
RA   Li K., Tong W.H., Hughes R.M., Rouault T.A.;
RT   "Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold
RT   protein, ISCU, in iron-sulfur cluster assembly.";
RL   J. Biol. Chem. 281:12344-12351(2006).
RN   [7]
RP   INVOLVEMENT IN MEIS.
RX   PubMed=18304497; DOI=10.1016/j.ajhg.2007.12.012;
RA   Mochel F., Knight M.A., Tong W.-H., Hernandez D., Ayyad K., Taivassalo T.,
RA   Andersen P.M., Singleton A., Rouault T.A., Fischbeck K.H., Haller R.G.;
RT   "Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes
RT   myopathy with exercise intolerance.";
RL   Am. J. Hum. Genet. 82:652-660(2008).
RN   [8]
RP   INTERACTION WITH HSCB.
RX   PubMed=20668094; DOI=10.1093/hmg/ddq301;
RA   Uhrigshardt H., Singh A., Kovtunovych G., Ghosh M., Rouault T.A.;
RT   "Characterization of the human HSC20, an unusual DnaJ type III protein,
RT   involved in iron-sulfur cluster biogenesis.";
RL   Hum. Mol. Genet. 19:3816-3834(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   COMPONENT OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=21298097; DOI=10.1371/journal.pone.0016199;
RA   Schmucker S., Martelli A., Colin F., Page A., Wattenhofer-Donze M.,
RA   Reutenauer L., Puccio H.;
RT   "Mammalian frataxin: an essential function for cellular viability through
RT   an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly
RT   complex.";
RL   PLoS ONE 6:e16199-e16199(2011).
RN   [11]
RP   PHOSPHORYLATION AT SER-14, AND MUTAGENESIS OF SER-14.
RX   PubMed=23508953; DOI=10.1074/jbc.m112.424499;
RA   La P., Yang G., Dennery P.A.;
RT   "Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation
RT   stabilizes ISCU protein: implications for iron metabolism.";
RL   J. Biol. Chem. 288:12901-12909(2013).
RN   [12]
RP   INTERACTION WITH HSPA9; NFS1 AND HSC20, FUNCTION, MUTAGENESIS OF ASP-71;
RP   ASN-122 AND HIS-137, AND FUNCTION OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=23940031; DOI=10.1074/jbc.m113.482042;
RA   Cai K., Frederick R.O., Kim J.H., Reinen N.M., Tonelli M., Markley J.L.;
RT   "Human mitochondrial chaperone (mtHSP70) and cysteine desulfurase (NFS1)
RT   bind preferentially to the disordered conformation, whereas co-chaperone
RT   (HSC20) binds to the structured conformation of the iron-sulfur cluster
RT   scaffold protein (ISCU).";
RL   J. Biol. Chem. 288:28755-28770(2013).
RN   [13]
RP   MUTAGENESIS OF CYS-69; CYS-95; CYS-130 AND CYS-138, SULFHYDRATION AT
RP   CYS-138, AND FUNCTION OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=24971490; DOI=10.1021/bi500532e;
RA   Bridwell-Rabb J., Fox N.G., Tsai C.L., Winn A.M., Barondeau D.P.;
RT   "Human frataxin activates Fe-S cluster biosynthesis by facilitating sulfur
RT   transfer chemistry.";
RL   Biochemistry 53:4904-4913(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   INTERACTION WITH GLRX5.
RX   PubMed=26100117; DOI=10.1002/jcb.25267;
RA   Liu G., Wang Y., Anderson G.J., Camaschella C., Chang Y., Nie G.;
RT   "Functional analysis of GLRX5 mutants reveals distinct functionalities of
RT   GLRX5 protein.";
RL   J. Cell. Biochem. 117:207-217(2016).
RN   [16]
RP   INTERACTION WITH HSPA9, AND SUBCELLULAR LOCATION.
RX   PubMed=26702583; DOI=10.1016/j.mito.2015.12.005;
RA   Shan Y., Cortopassi G.;
RT   "Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-
RT   sulfur cluster assembly.";
RL   Mitochondrion 26:94-103(2016).
RN   [17]
RP   FUNCTION, MUTAGENESIS OF MET-140, AND FUNCTION OF CORE (FE-S) CLUSTER
RP   ASSEMBLY COMPLEX.
RX   PubMed=30031876; DOI=10.1016/j.biochi.2018.07.012;
RA   Fox N.G., Martelli A., Nabhan J.F., Janz J., Borkowska O., Bulawa C.,
RA   Yue W.W.;
RT   "Zinc(II) binding on human wild-type ISCU and Met140 variants modulates
RT   NFS1 desulfurase activity.";
RL   Biochimie 152:211-218(2018).
RN   [18]
RP   FUNCTION (ISOFORM 2), AND INTERACTION WITH HSCB AND NFS1 (ISOFORM 2).
RX   PubMed=29309586; DOI=10.1093/hmg/ddy004;
RA   Kim K.S., Maio N., Singh A., Rouault T.A.;
RT   "Cytosolic HSC20 integrates de novo iron-sulfur cluster biogenesis with the
RT   CIAO1-mediated transfer to recipients.";
RL   Hum. Mol. Genet. 27:837-852(2018).
RN   [19]
RP   INTERACTION WITH THE CYSTEINE DESULFURASE COMPLEX AND FXN, FUNCTION, AND
RP   FUNCTION OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=29576242; DOI=10.1016/j.jinorgbio.2018.03.007;
RA   Cai K., Frederick R.O., Tonelli M., Markley J.L.;
RT   "Interactions of iron-bound frataxin with ISCU and ferredoxin on the
RT   cysteine desulfurase complex leading to Fe-S cluster assembly.";
RL   J. Inorg. Biochem. 183:107-116(2018).
RN   [20] {ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW}
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 1-142 (ISOFORM 2) IN COMPLEX WITH
RP   ZINC ION; NFS1 AND LYRM4, SUBUNIT, INTERACTION WITH NFS1, AND COMPONENT OF
RP   CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=29097656; DOI=10.1038/s41467-017-01497-1;
RA   Boniecki M.T., Freibert S.A., Muhlenhoff U., Lill R., Cygler M.;
RT   "Structure and functional dynamics of the mitochondrial Fe/S cluster
RT   synthesis complex.";
RL   Nat. Commun. 8:1287-1287(2017).
RN   [21] {ECO:0007744|PDB:6NZU}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.20 ANGSTROMS) OF 34-157 IN COMPLEX WITH
RP   ZINC ION; NFS1; LYRM4 AND FXN, SUBUNIT, COMPONENT OF CORE (FE-S) CLUSTER
RP   ASSEMBLY COMPLEX, AND INTERACTION WITH FXN.
RX   PubMed=31101807; DOI=10.1038/s41467-019-09989-y;
RA   Fox N.G., Yu X., Feng X., Bailey H.J., Martelli A., Nabhan J.F.,
RA   Strain-Damerell C., Bulawa C., Yue W.W., Han S.;
RT   "Structure of the human frataxin-bound iron-sulfur cluster assembly complex
RT   provides insight into its activation mechanism.";
RL   Nat. Commun. 10:2210-2210(2019).
RN   [22] {ECO:0007744|PDB:6UXE, ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2, ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK}
RP   X-RAY CRYSTALLOGRAPHY (1.57 ANGSTROMS) OF 35-167 IN COMPLEX WITH NFS1 AND
RP   LYRM4, MUTAGENESIS OF TYR-35, SUBUNIT, SITE, AND FUNCTION.
RX   PubMed=34824239; DOI=10.1038/s41467-021-27122-w;
RA   Freibert S.A., Boniecki M.T., Stuempfig C., Schulz V., Krapoth N.,
RA   Winge D.R., Muehlenhoff U., Stehling O., Cygler M., Lill R.;
RT   "N-terminal tyrosine of ISCU2 triggers [2Fe-2S] cluster synthesis by ISCU2
RT   dimerization.";
RL   Nat. Commun. 12:6902-6902(2021).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-12, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: [Isoform 1]: Mitochondrial scaffold protein, of the core
CC       iron-sulfur cluster (ISC) assembly complex, that provides the
CC       structural architecture on which the [2Fe-2S] clusters are assembled
CC       (PubMed:34824239). The core iron-sulfur cluster (ISC) assembly complex
CC       is involved in the de novo synthesis of a [2Fe-2S] cluster, the first
CC       step of the mitochondrial iron-sulfur protein biogenesis. This process
CC       is initiated by the cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1)
CC       that produces persulfide which is delivered on the scaffold protein
CC       ISCU in a FXN-dependent manner. Then this complex is stabilized by FDX2
CC       which provides reducing equivalents to accomplish the [2Fe-2S] cluster
CC       assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to
CC       chaperone proteins, including HSCB, HSPA9 and GLRX5 (Probable)
CC       (PubMed:24971490, PubMed:29576242, PubMed:30031876, PubMed:34824239).
CC       Exists as two slow interchanging conformational states, a structured
CC       (S) and disordered (D) form (PubMed:23940031). May modulate NFS1
CC       desulfurase activity in a zinc-dependent manner (PubMed:30031876).
CC       Modulates the interaction between FXN and the cysteine desulfurase
CC       complex (PubMed:29576242). {ECO:0000269|PubMed:23940031,
CC       ECO:0000269|PubMed:24971490, ECO:0000269|PubMed:29576242,
CC       ECO:0000269|PubMed:30031876, ECO:0000269|PubMed:34824239,
CC       ECO:0000305|PubMed:23940031}.
CC   -!- FUNCTION: [Isoform 2]: Cytoplasmic scaffold protein, of the cytoplasmic
CC       core iron-sulfur cluster (ISC) assembly complex that provides the
CC       structural architecture on which the Fe-S clusters are assembled and
CC       may be involved in the cytoplasmic iron-sulfur protein biogenesis.
CC       {ECO:0000269|PubMed:16517407, ECO:0000269|PubMed:16527810,
CC       ECO:0000269|PubMed:29309586}.
CC   -!- SUBUNIT: [Isoform 1]: Homodimer; Tyr-35-mediated dimerization of two
CC       iron- and sulfide-containing ISCU subunit bind to the cysteine
CC       desulfurase complex (PubMed:31101807, PubMed:34824239). Component of
CC       the mitochondrial core iron-sulfur cluster (ISC) complex composed of
CC       NFS1, LYRM4, NDUFAB1, ISCU, FXN, and FDX2; this complex is an
CC       heterohexamer containing two copies of each monomer (Probable)
CC       (PubMed:21298097, PubMed:31101807). Interacts (D-state) with NFS1
CC       (homodimer form); each monomer interacts with the C-terminal regions of
CC       each NFS1 monomer (PubMed:11060020, PubMed:23940031). Interacts
CC       (monomer form) with FXN (via ferrous form); the interaction is possible
CC       when both are bound to the dimeric form of the cysteine desulfurase
CC       complex (NFS1:LYRM4) and enhances FXN interaction to the dimeric form
CC       of the cysteine desulfurase complex (NFS1:LYRM4) (PubMed:29576242,
CC       PubMed:31101807). Interacts with GLRX5 (PubMed:26100117). Interacts (D-
CC       state) with HSPA9 (PubMed:23940031, PubMed:26702583). Interacts (S-
CC       state) with HSCB; this interaction stimulates the ATPase activity of
CC       HSPA9 (PubMed:20668094, PubMed:23940031). {ECO:0000269|PubMed:11060020,
CC       ECO:0000269|PubMed:20668094, ECO:0000269|PubMed:21298097,
CC       ECO:0000269|PubMed:23940031, ECO:0000269|PubMed:26100117,
CC       ECO:0000269|PubMed:26702583, ECO:0000269|PubMed:29576242,
CC       ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
CC       ECO:0000305|PubMed:29097656}.
CC   -!- SUBUNIT: [Isoform 2]: Component of the cytoplasmic core iron-sulfur
CC       cluster (ISC) complex composed at least of NFS1, LYRM4, and ISCU; this
CC       complex interacts with FXN (PubMed:29309586). Monomer; each monomer
CC       binds to the C-terminal regions of NFS1 (cytoplasmic and homodimer
CC       form) (PubMed:11060020, PubMed:29097656). Interacts with NFS1
CC       (cytoplasmic and homodimer form); this interaction promotes de novo
CC       iron-sulfur cluster formation (PubMed:16527810, PubMed:29309586).
CC       Interacts with HSCB (cytoplasmic form); this interaction stabilizes the
CC       (Fe-S) clusters on ISCU (PubMed:29309586).
CC       {ECO:0000269|PubMed:11060020, ECO:0000269|PubMed:16527810,
CC       ECO:0000269|PubMed:29097656, ECO:0000269|PubMed:29309586}.
CC   -!- INTERACTION:
CC       Q9H1K1; Q6RW13: AGTRAP; NbExp=3; IntAct=EBI-1047335, EBI-741181;
CC       Q9H1K1; Q8N9N5: BANP; NbExp=3; IntAct=EBI-1047335, EBI-744695;
CC       Q9H1K1; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-1047335, EBI-11524851;
CC       Q9H1K1; P0C7W6: CCDC172; NbExp=3; IntAct=EBI-1047335, EBI-2548868;
CC       Q9H1K1; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-1047335, EBI-10175124;
CC       Q9H1K1; Q08379: GOLGA2; NbExp=3; IntAct=EBI-1047335, EBI-618309;
CC       Q9H1K1; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-1047335, EBI-5916454;
CC       Q9H1K1; P00492: HPRT1; NbExp=4; IntAct=EBI-1047335, EBI-748210;
CC       Q9H1K1; Q13422: IKZF1; NbExp=3; IntAct=EBI-1047335, EBI-745305;
CC       Q9H1K1; O76011: KRT34; NbExp=3; IntAct=EBI-1047335, EBI-1047093;
CC       Q9H1K1; Q6A162: KRT40; NbExp=3; IntAct=EBI-1047335, EBI-10171697;
CC       Q9H1K1; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-1047335, EBI-739832;
CC       Q9H1K1; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-1047335, EBI-10172526;
CC       Q9H1K1; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-1047335, EBI-10172876;
CC       Q9H1K1; P37198: NUP62; NbExp=6; IntAct=EBI-1047335, EBI-347978;
CC       Q9H1K1; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-1047335, EBI-79165;
CC       Q9H1K1; P21912: SDHB; NbExp=8; IntAct=EBI-1047335, EBI-1056481;
CC       Q9H1K1; P31947: SFN; NbExp=2; IntAct=EBI-1047335, EBI-476295;
CC       Q9H1K1; P62258: YWHAE; NbExp=3; IntAct=EBI-1047335, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion
CC       {ECO:0000269|PubMed:11060020, ECO:0000269|PubMed:26702583}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Nucleus
CC       {ECO:0000269|PubMed:11060020}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=ISCU2;
CC         IsoId=Q9H1K1-1; Sequence=Displayed;
CC       Name=2; Synonyms=ISCU1;
CC         IsoId=Q9H1K1-2; Sequence=VSP_013492;
CC   -!- TISSUE SPECIFICITY: Detected in heart, liver, skeletal muscle, brain,
CC       pancreas, kidney, lung and placenta. {ECO:0000269|PubMed:11060020,
CC       ECO:0000269|PubMed:8875867}.
CC   -!- PTM: Phosphorylation at Ser-14 is required for ISCU protein
CC       stabilization in the cytosol, whereas dephosphorylation of Ser-14, due
CC       to the inhibition of mTORC1 (mammalian target of rapamycin complex 1)
CC       complex, leads to degradation of the precursor form and ultimately to a
CC       decrease in the mitochondrial mature form.
CC       {ECO:0000269|PubMed:23508953}.
CC   -!- PTM: Cysteine persulfide is reduced by thiol-containing molecules such
CC       as glutathione and L-cysteine. {ECO:0000250|UniProtKB:Q9D7P6}.
CC   -!- DISEASE: Myopathy with exercise intolerance Swedish type (MEIS)
CC       [MIM:255125]: Autosomal recessive metabolic disease characterized by
CC       lifelong severe exercise intolerance, in which minor exertion causes
CC       fatigue of active muscles, shortness of breath, and cardiac
CC       palpitations in association with lactic acidosis. The biochemical
CC       phenotype is characterized by a deficiency in mitochondrial iron-sulfur
CC       proteins and impaired muscle oxidative metabolism.
CC       {ECO:0000269|PubMed:18304497}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NifU family. {ECO:0000305}.
CC   -!- CAUTION: [Isoform 1]: Previous publications report that ISCU could
CC       provide the architecture on which both [2Fe-2S] and [4Fe-4S] clusters
CC       could be assembled (PubMed:16517407, PubMed:16527810, PubMed:23940031).
CC       Recent reports confirm that only [2Fe-2S] clusters are formed by the
CC       core ISC assembly complex (PubMed:34824239).
CC       {ECO:0000269|PubMed:16517407, ECO:0000269|PubMed:16527810,
CC       ECO:0000269|PubMed:23940031, ECO:0000269|PubMed:34824239}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY009127; AAG37427.1; -; mRNA.
DR   EMBL; AY009128; AAG37428.1; -; mRNA.
DR   EMBL; AC008119; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011906; AAH11906.1; -; mRNA.
DR   EMBL; BC061903; AAH61903.1; -; mRNA.
DR   EMBL; U47101; AAC50885.1; -; mRNA.
DR   CCDS; CCDS44966.1; -. [Q9H1K1-1]
DR   CCDS; CCDS9118.1; -. [Q9H1K1-2]
DR   RefSeq; NP_001306971.1; NM_001320042.1.
DR   RefSeq; NP_055116.1; NM_014301.4. [Q9H1K1-2]
DR   RefSeq; NP_998760.1; NM_213595.4. [Q9H1K1-1]
DR   PDB; 5KZ5; EM; 14.30 A; a/b/c/d/e/f/g/h/i/j/k/l=50-167.
DR   PDB; 5WKP; X-ray; 3.15 A; D/H=38-167.
DR   PDB; 5WLW; X-ray; 3.32 A; D/H=38-167.
DR   PDB; 6NZU; EM; 3.20 A; D/H=34-157.
DR   PDB; 6UXE; X-ray; 1.57 A; D=35-167.
DR   PDB; 6W1D; X-ray; 1.79 A; D=35-167.
DR   PDB; 6WI2; X-ray; 1.95 A; D=35-167.
DR   PDB; 6WIH; X-ray; 1.90 A; D=35-167.
DR   PDB; 7RTK; X-ray; 2.50 A; D=35-167.
DR   PDB; 8PK8; EM; 2.49 A; D=35-167.
DR   PDB; 8PK9; EM; 2.58 A; D=35-167.
DR   PDB; 8PKA; EM; 2.75 A; D=35-167.
DR   PDB; 8RMC; EM; 2.26 A; D/H=35-167.
DR   PDB; 8RMD; EM; 2.52 A; D/H=35-167.
DR   PDB; 8RME; EM; 2.49 A; D/H=35-167.
DR   PDB; 8RMF; EM; 2.33 A; D/H=35-167.
DR   PDB; 8RMG; EM; 2.46 A; D/H=35-167.
DR   PDB; 8TVT; X-ray; 2.00 A; D=35-167.
DR   PDBsum; 5KZ5; -.
DR   PDBsum; 5WKP; -.
DR   PDBsum; 5WLW; -.
DR   PDBsum; 6NZU; -.
DR   PDBsum; 6UXE; -.
DR   PDBsum; 6W1D; -.
DR   PDBsum; 6WI2; -.
DR   PDBsum; 6WIH; -.
DR   PDBsum; 7RTK; -.
DR   PDBsum; 8PK8; -.
DR   PDBsum; 8PK9; -.
DR   PDBsum; 8PKA; -.
DR   PDBsum; 8RMC; -.
DR   PDBsum; 8RMD; -.
DR   PDBsum; 8RME; -.
DR   PDBsum; 8RMF; -.
DR   PDBsum; 8RMG; -.
DR   PDBsum; 8TVT; -.
DR   AlphaFoldDB; Q9H1K1; -.
DR   BMRB; Q9H1K1; -.
DR   EMDB; EMD-0560; -.
DR   EMDB; EMD-17732; -.
DR   EMDB; EMD-17733; -.
DR   EMDB; EMD-17734; -.
DR   EMDB; EMD-19356; -.
DR   EMDB; EMD-19357; -.
DR   EMDB; EMD-19359; -.
DR   EMDB; EMD-19360; -.
DR   EMDB; EMD-19361; -.
DR   EMDB; EMD-8301; -.
DR   SASBDB; Q9H1K1; -.
DR   SMR; Q9H1K1; -.
DR   BioGRID; 117038; 51.
DR   ComplexPortal; CPX-5641; Mitochondrial NIAUFX iron-sulfur cluster assembly complex.
DR   CORUM; Q9H1K1; -.
DR   DIP; DIP-39616N; -.
DR   FunCoup; Q9H1K1; 2720.
DR   IntAct; Q9H1K1; 37.
DR   MINT; Q9H1K1; -.
DR   STRING; 9606.ENSP00000310623; -.
DR   GlyGen; Q9H1K1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H1K1; -.
DR   MetOSite; Q9H1K1; -.
DR   PhosphoSitePlus; Q9H1K1; -.
DR   BioMuta; ISCU; -.
DR   DMDM; 313104118; -.
DR   jPOST; Q9H1K1; -.
DR   MassIVE; Q9H1K1; -.
DR   PaxDb; 9606-ENSP00000310623; -.
DR   PeptideAtlas; Q9H1K1; -.
DR   ProteomicsDB; 80422; -. [Q9H1K1-1]
DR   ProteomicsDB; 80423; -. [Q9H1K1-2]
DR   Pumba; Q9H1K1; -.
DR   TopDownProteomics; Q9H1K1-1; -. [Q9H1K1-1]
DR   Antibodypedia; 30765; 274 antibodies from 28 providers.
DR   DNASU; 23479; -.
DR   Ensembl; ENST00000311893.14; ENSP00000310623.9; ENSG00000136003.16. [Q9H1K1-1]
DR   Ensembl; ENST00000392807.8; ENSP00000376554.4; ENSG00000136003.16. [Q9H1K1-2]
DR   GeneID; 23479; -.
DR   KEGG; hsa:23479; -.
DR   MANE-Select; ENST00000311893.14; ENSP00000310623.9; NM_213595.4; NP_998760.1.
DR   UCSC; uc001tnc.5; human. [Q9H1K1-1]
DR   AGR; HGNC:29882; -.
DR   CTD; 23479; -.
DR   DisGeNET; 23479; -.
DR   GeneCards; ISCU; -.
DR   HGNC; HGNC:29882; ISCU.
DR   HPA; ENSG00000136003; Low tissue specificity.
DR   MalaCards; ISCU; -.
DR   MIM; 255125; phenotype.
DR   MIM; 611911; gene.
DR   OpenTargets; ENSG00000136003; -.
DR   Orphanet; 43115; Hereditary myopathy with lactic acidosis due to ISCU deficiency.
DR   VEuPathDB; HostDB:ENSG00000136003; -.
DR   eggNOG; KOG3361; Eukaryota.
DR   GeneTree; ENSGT00390000015813; -.
DR   HOGENOM; CLU_079283_1_2_1; -.
DR   InParanoid; Q9H1K1; -.
DR   OMA; SMVTEMV; -.
DR   OrthoDB; 1925777at2759; -.
DR   PAN-GO; Q9H1K1; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9H1K1; -.
DR   PathwayCommons; Q9H1K1; -.
DR   Reactome; R-HSA-1362409; Mitochondrial iron-sulfur cluster biogenesis. [Q9H1K1-1]
DR   Reactome; R-HSA-9694301; Maturation of replicase proteins.
DR   Reactome; R-HSA-9854311; Maturation of TCA enzymes and regulation of TCA cycle. [Q9H1K1-1]
DR   Reactome; R-HSA-9865881; Complex III assembly. [Q9H1K1-1]
DR   SignaLink; Q9H1K1; -.
DR   SIGNOR; Q9H1K1; -.
DR   BioGRID-ORCS; 23479; 787 hits in 1130 CRISPR screens.
DR   ChiTaRS; ISCU; human.
DR   GeneWiki; ISCU; -.
DR   GenomeRNAi; 23479; -.
DR   Pharos; Q9H1K1; Tbio.
DR   PRO; PR:Q9H1K1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9H1K1; protein.
DR   Bgee; ENSG00000136003; Expressed in heart right ventricle and 211 other cell types or tissues.
DR   ExpressionAtlas; Q9H1K1; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC-UCL.
DR   GO; GO:1990229; C:iron-sulfur cluster assembly complex; NAS:ComplexPortal.
DR   GO; GO:0099128; C:mitochondrial [2Fe-2S] assembly complex; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:HGNC-UCL.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IBA:GO_Central.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:FlyBase.
DR   GO; GO:0005506; F:iron ion binding; TAS:UniProtKB.
DR   GO; GO:0140132; F:iron-sulfur cluster chaperone activity; IDA:FlyBase.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:HGNC-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IDA:UniProtKB.
DR   GO; GO:0044572; P:[4Fe-4S] cluster assembly; IDA:UniProtKB.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IMP:GO_Central.
DR   GO; GO:1904439; P:negative regulation of iron ion import across plasma membrane; IMP:ARUK-UCL.
DR   GO; GO:1902958; P:positive regulation of mitochondrial electron transport, NADH to ubiquinone; IMP:ARUK-UCL.
DR   CDD; cd06664; IscU_like; 1.
DR   FunFam; 3.90.1010.10:FF:000008; Iron-sulfur cluster assembly enzyme; 1.
DR   Gene3D; 3.90.1010.10; -; 1.
DR   InterPro; IPR011339; ISCU.
DR   InterPro; IPR002871; NIF_FeS_clus_asmbl_NifU_N.
DR   NCBIfam; TIGR01999; iscU; 1.
DR   PANTHER; PTHR10093; IRON-SULFUR CLUSTER ASSEMBLY ENZYME NIFU HOMOLOG; 1.
DR   Pfam; PF01592; NifU_N; 1.
DR   SUPFAM; SSF82649; SufE/NifU; 1.
DR   neXtProt; NX_Q9H1K1; -.
DR   PharmGKB; PA162392328; -.
DR   TreeFam; TF105422; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Iron; Metal-binding;
KW   Mitochondrion; Nucleus; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..34
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           35..167
FT                   /note="Iron-sulfur cluster assembly enzyme ISCU"
FT                   /id="PRO_0000019692"
FT   ACT_SITE        69
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7P6"
FT   ACT_SITE        138
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:O29689"
FT   BINDING         71
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:31101807,
FT                   ECO:0007744|PDB:6NZU"
FT   BINDING         95
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:31101807,
FT                   ECO:0007744|PDB:6NZU"
FT   BINDING         138
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:31101807,
FT                   ECO:0007744|PDB:6NZU"
FT   SITE            35
FT                   /note="Mediates ISCU dimerization and de novo [2Fe-2S]
FT                   cluster assembly"
FT                   /evidence="ECO:0000269|PubMed:34824239"
FT   MOD_RES         14
FT                   /note="Phosphoserine; by MTOR"
FT                   /evidence="ECO:0000269|PubMed:23508953"
FT   MOD_RES         69
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D7P6"
FT   MOD_RES         138
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000305|PubMed:24971490"
FT   VAR_SEQ         1..38
FT                   /note="MAAAGAFRLRRAASALLLRSPRLPARELSAPARLYHKK -> MVLIDMSVDL
FT                   STQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11060020"
FT                   /id="VSP_013492"
FT   VARIANT         12
FT                   /note="A -> V (in dbSNP:rs2287555)"
FT                   /evidence="ECO:0000269|PubMed:11060020,
FT                   ECO:0000269|PubMed:15489334, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT                   /id="VAR_060728"
FT   MUTAGEN         14
FT                   /note="S->A: Loss of phosphorylation. Does not affect
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:23508953"
FT   MUTAGEN         35
FT                   /note="Y->A: Does not affect mitochondrial localization.
FT                   Loss of iron-sulfur cluster biogenesis. Does not affect
FT                   reductive cleavage of the ISCU2-bound-persulfide by FDX2."
FT                   /evidence="ECO:0000269|PubMed:34824239"
FT   MUTAGEN         69
FT                   /note="C->A: Does not affect ISC complex formation. Does
FT                   not affect the unstimulated cysteine desulfurase activity
FT                   in the absence of FXN. Does not affect the cysteine
FT                   desulfurase activity in the presence of FXN. Slightly
FT                   decreases the cysteine desulfurase activity in the presence
FT                   of FXN; when associated with A-95. Does not affect iron
FT                   based stimulation of the cysteine desulfurase activity in
FT                   the presence of FXN. Does not affect iron based stimulation
FT                   of the cysteine desulfurase activity in the presence of
FT                   FXN; when associated with A-95. Loss of the [2Fe-2S]
FT                   cluster formation."
FT   MUTAGEN         69
FT                   /note="C->S: Does not affect the cysteine desulfurase
FT                   activity in the presence of FXN. Does not affect iron based
FT                   stimulation of the cysteine desulfurase activity in the
FT                   presence of FXN."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         71
FT                   /note="D->A: Stabilizes the D-state."
FT                   /evidence="ECO:0000269|PubMed:23940031"
FT   MUTAGEN         71
FT                   /note="D->V: Stabilizes the S-state."
FT                   /evidence="ECO:0000269|PubMed:23940031"
FT   MUTAGEN         95
FT                   /note="C->A: Does not affect ISC complex formation. Does
FT                   not affect the unstimulated cysteine desulfurase activity
FT                   in the absence of FXN. Does not affect the cysteine
FT                   desulfurase activity in the presence of FXN. Slightly
FT                   decreases the cysteine desulfurase activity in the presence
FT                   of FXN; when associated with A-95. Does not affect iron
FT                   based stimulation of the cysteine desulfurase activity in
FT                   the presence of FXN. Does not affect iron based stimulation
FT                   of the cysteine desulfurase activity in the presence of
FT                   FXN; when associated with A.69. Loss of the [2Fe-2S]
FT                   cluster formation."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         95
FT                   /note="C->S: Slightly decrease the cysteine desulfurase
FT                   activity in the presence of FXN. Does not affect iron based
FT                   stimulation of the cysteine desulfurase activity in the
FT                   presence of FXN."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         122
FT                   /note="N->A: Stabilizes the S-state."
FT                   /evidence="ECO:0000269|PubMed:23940031"
FT   MUTAGEN         130
FT                   /note="C->S: Does not affect the unstimulated cysteine
FT                   desulfurase activity in the absence of FXN. Does not affect
FT                   the cysteine desulfurase activity in the presence of FXN.
FT                   Does not affect iron based stimulation of the cysteine
FT                   desulfurase activity in the presence of FXN. Does not
FT                   affect the [2Fe-2S] cluster assembly."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         137
FT                   /note="H->A: Stabilizes the D-state."
FT                   /evidence="ECO:0000269|PubMed:23940031"
FT   MUTAGEN         138
FT                   /note="C->A: Does not affect ISC complex formation. Does
FT                   not affect the unstimulated cysteine desulfurase activity
FT                   in the absence of FXN. Loss of iron-based stimulation of
FT                   the cysteine desulfurase activity in the presence of FXN.
FT                   Loss of the [2Fe-2S] cluster formation."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         138
FT                   /note="C->S: Loss of iron-based stimulation of the cysteine
FT                   desulfurase activity in the presence of FXN."
FT                   /evidence="ECO:0000269|PubMed:24971490"
FT   MUTAGEN         140
FT                   /note="M->I: Does not affect the SDA complex formation.
FT                   Abolishes desulfurase activity of SDA complex when zinc ion
FT                   is bound. Activated by FXN when component of SDAU complex."
FT                   /evidence="ECO:0000269|PubMed:30031876"
FT   MUTAGEN         140
FT                   /note="M->L: Does not affect the SDA complex formation.
FT                   Abolishes desulfurase activity of SDA complex when zinc ion
FT                   is bound. Activated by FXN when component of SDAU complex."
FT                   /evidence="ECO:0000269|PubMed:30031876"
FT   MUTAGEN         140
FT                   /note="M->V: Does not affect the SDA complex formation.
FT                   Abolishes desulfurase activity of SDA complex when zinc ion
FT                   is bound. Activated by FXN when component of SDAU complex."
FT                   /evidence="ECO:0000269|PubMed:30031876"
FT   CONFLICT        7
FT                   /note="F -> G (in Ref. 1; AAG37428 and 3; AAH11906)"
FT                   /evidence="ECO:0000305"
FT   HELIX           37..44
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:5WLW"
FT   STRAND          59..66
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          71..79
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          83..94
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           96..109
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           114..117
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           122..129
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           136..157
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   BINDING         Q9H1K1-2:46
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared with NFS1"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0007744|PDB:5WLW"
FT   BINDING         Q9H1K1-2:70
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared with NFS1"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0007744|PDB:5WLW"
FT   BINDING         Q9H1K1-2:112
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared with NFS1"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0007744|PDB:5WLW"
SQ   SEQUENCE   167 AA;  17999 MW;  0166D3EC9F1EEB47 CRC64;
     MAAAGAFRLR RAASALLLRS PRLPARELSA PARLYHKKVV DHYENPRNVG SLDKTSKNVG
     TGLVGAPACG DVMKLQIQVD EKGKIVDARF KTFGCGSAIA SSSLATEWVK GKTVEEALTI
     KNTDIAKELC LPPVKLHCSM LAEDAIKAAL ADYKLKQEPK KGEAEKK
//
